Fibrosing myopathy in systemic sclerosis associates with higher mortality.

about

Fibrosing myopathy in systemic sclerosis associates with higher mortality.

Item

http://www.wikidata.org/entity/Q38763676

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Fibrosing myopathy in systemic sclerosis associates with higher mortality.

@en

type

Item

label

Fibrosing myopathy in systemic sclerosis associates with higher mortality.

@en

prefLabel

Fibrosing myopathy in systemic sclerosis associates with higher mortality.

@en

P1476

Fibrosing myopathy in systemic sclerosis associates with higher mortality.

@en

P2093

Ami A Shah

http://www.w3.org/2001/XMLSchema#string

Andrea M Corse

http://www.w3.org/2001/XMLSchema#string

Andrew L Mammen

http://www.w3.org/2001/XMLSchema#string

Fredrick M Wigley

http://www.w3.org/2001/XMLSchema#string

Julie J Paik

http://www.w3.org/2001/XMLSchema#string

Laura K Hummers

http://www.w3.org/2001/XMLSchema#string

Livia Casciola-Rosen

http://www.w3.org/2001/XMLSchema#string

P2860

Spirometric reference values from a sample of the general U.S. population

The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit.

Spectrum of Muscle Histopathologic Findings in Forty-Two Scleroderma Patients With Weakness.

Muscle edema: classification, mechanisms, and interpretation.

Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.

The 15% rule in scleroderma: the frequency of severe organ complications in systemic sclerosis. A systematic review.

Independent Association of Severity of Muscle Weakness With Disability as Measured by the Health Assessment Questionnaire Disability Index in Scleroderma.

Myopathy is a poor prognostic feature in systemic sclerosis: results from the Canadian Scleroderma Research Group (CSRG) cohort.

Anti-U3 RNP autoantibodies in systemic sclerosis.

Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations.

P31

scholarly article

P356

10.1002/ACR.23291

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28544788

http://www.w3.org/2001/XMLSchema#string

P932

5791890

http://www.w3.org/2001/XMLSchema#string